H+H International A/S
On 4 March 2021, H+H International A/S (hereinafter referred to as "H+H" or "the Company") initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the "Safe Harbour Regulation").
The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2021. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 100 million, and no more than 1,728,136 shares, corresponding to approximately 9.6 percent of the share capital of the Company.
The following transactions were executed under the share buy-back programme from 4 March 2021 to 9 March 2021:
| No. of shares | Average price (DKK) | Total value (DKK) | |
| 4 March 2021 | 4,500 | 147.24 | 662,580.00 |
| 5 March 2021 | 4,500 | 152.11 | 684,495.00 |
| 8 March 2021 | 5,000 | 148.45 | 742,250.00 |
| 9 March 2021 | 4,500 | 149.02 | 670,590.00 |
| Total | 18,500 | 2,759,915.00 | |
| Accumulated under the programme | 18,500 | 2,759,915.00 |
Details of each transaction are included as an appendix to this announcement.
Following these transactions, H+H holds 88,700 shares as treasury shares, corresponding to 0.49 percent of the Company’s total share capital.
For further information please contact:
Andreas Holkjær
Investor Relations and Treasury Manager
+45 24 48 03 67
aho@HplusH.com
Attachments
- 405 - Transactions in connection with share buy-back programme
- 405 - Appendix - Specification - 04.03.2021 to 09.03.2021
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd24.12.2025 14:36:11 CET | Press release
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
The Magnum Ice Cream Company N.V.24.12.2025 11:52:30 CET | Press release
Director/PDMR Shareholding
Afarak Group SE24.12.2025 10:00:00 CET | Press release
AFARAK GROUP SE: DISTRIBUTION OF ASSETS FROM THE RESERVE FOR INVESTED UNRESTRICTED EQUITY
Sanofi Winthrop Industrie24.12.2025 07:15:00 CET | Press release
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
FLSmidth A/S24.12.2025 07:00:00 CET | Press release
FLSmidth: Transactions under share buy-back programme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
